Skip to main content
SBCSBC Medical Group Holdings IncoBuy Wait7.5·$5.60
SBC · Why this verdict

Why SBC Medical Group Holdings Inco (SBC) is rated BUY WAIT

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictBUY WAIT
Overall score7.5/10
ConfidenceMEDIUM
MacroRISK_OFF
TrendMatrix Research · core thesis

Engine thesis — one sentence

SBC Medical is a high-quality, fast-growing business with 27% margins and 193% cash conversion, but the stock sits at its 52-week high with only 7.0% upside to the analyst target and extreme volatility.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Quality is high at 9.2/10, with 27% margins, 193% free cash flow to net income, a Piotroski F-Score of 9/9 and a Rule of 40 of 88.

↑Improving
Quality breakdown
Expectation
Margins should stay above 20% and free cash flow conversion above 100% over the next 12 months.

CounterCash conversion of 193% and margins this high are unusual for a consulting-services firm and may reflect timing of prepayments that will reverse.

Growth is strong at 35% YoY, ranking the company an industry growth leader among peers.

↑Improving
Growth breakdown
Expectation
Revenue growth should stay above 20% YoY through the next 4 quarters.

CounterA PEG of 2.06 suggests the market already pays a full price for this growth, leaving little room if growth slows.

The stock is within 0.4% of its 52-week high with only 7.0% upside to the analyst target against 15.0% downside, a reward-to-risk of 0.46.

↓Deteriorating
Bear case
Expectation
Analyst targets should be raised above $9, or price should consolidate, to restore a positive reward-to-risk.

CounterMomentum is strong at 8.7/10 with rising volume, so a stock at highs can keep rising and the target may simply lag.

Momentum is overbought (RSI 75) after an extreme 18.9% gap up and a 6.3x volume surge, with implied volatility at 171%.

↑Improving
Momentum breakdown
Expectation
Price should consolidate without losing more than 15% from the current $7.35.

CounterOverbought readings after a volume surge on an up move often precede a pullback, and a put/call ratio of 9.00 shows heavy hedging demand.

The latest quarter beat with EPS of 0.15 versus 0.12 expected, and earnings have met or beaten estimates in 3 of the last 4 quarters.

↑Improving
Earnings
Expectation
EPS should stay at or above 0.12 per quarter.

CounterOne quarter was a 14.89% miss and another only in line, so the beat record is not uniformly strong.

Per-dimension breakdown

Value

7.7/10data confidence 100%
ComponentSub-score
P/E8.5
P/S8.0
EV/EBITDA8.0
Fwd P/E9.2
PEG4.2
Analyst target9.0
  • ▸Forward P/E: 10.9x
  • ▸PEG: 2.35
  • ▸Attractively valued

Quality

9.2/10data confidence 100%
ComponentSub-score
ROE6.4
ROA8.5
Gross margin10.0
Op margin10.0
Net margin10.0
Current ratio9.3
FCF quality10.0
Moat8.4
Rule of 409.5
Piotroski F10.0
  • ▸Strong margins: 27%
  • ▸Excellent cash conversion: 193% FCF/NI
  • ▸Wide economic moat
  • ▸Compounder quality: strong returns + growth

Growth

8.2/10data confidence 67%
ComponentSub-score
Rev growth10.0
EPS growth6.5
  • ▸Strong growth: 35% YoY

Momentum

5.7/10data confidence 100%
ComponentSub-score
RSI5.5
MACD7.4
OBV1.0
MA position9.0
Volume5.5
  • ▸Volume distribution (falling OBV)
  • ▸Above 200-day MA

Sentiment

7.5/10data confidence 100%
ComponentSub-score
LLM sentiment5.8
Analyst rating7.1
Price target9.9
  • ▸Light analyst coverage (4.0) — signal dampened
  • ▸Analyst upside: 79%

Insider

7.3/10data confidence 75%
ComponentSub-score
materiality5.0
holder change10.0
notable moves7.0
  • ▸No net insider activity — $0 (0.000% of mkt cap)
  • ▸Institutions accumulating

Peer rank

7.3/10data confidence 80%
ComponentSub-score
value rank5.5
quality rank6.3
growth rank8.9
  • ▸Attractive P/E vs peers
  • ▸Industry growth leader

Technical

5.7/10data confidence 100%
ComponentSub-score
bollinger4.7
support resistance7.0
52w position5.2
gap6.0

Risk (lower is worse)

4.9/10data confidence 100%
ComponentSub-score
short interest7.8
days to cover6.1
volatility0.0
put call2.2
implied vol0.0
max pain risk3.0
beta9.9
debt equity9.4
news risk6.0
  • ▸Elevated put/call: 1.67
  • ▸High IV: 95%
  • ▸Above max pain $5
  • ▸Concentration risks: 2 MED (10-K Item 1A)

Catalyst

7.6/10data confidence 100%
ComponentSub-score
erm5.0
earnings history10.0
earnings timing5.0
surprise avg10.0
news activity8.0

How the verdict was assembled

Engine trigger

Value play: 51% MoS with quality 9.2. (held at prior verdict — engine reading is near the momentum/RSI threshold; will commit on clearer signal).

Engine technical detail
verdict_path: L4:PATH_A_VALUE_MOS33|STABILIZER:PROMOTE_DEAD_ZONE|ENTRY_STICKY:WITHIN_BAND
Passed (9)
  • MOMENTUM:5.7>=5.5
  • ASYMMETRY:3.5>=1.5
  • INSIDER:OK
  • NEWS_BOOST:ANALYST:0.60
  • NEWS_BOOST:ANALYST_CLUSTER(3)
  • EARNINGS_PROXIMITY:126d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
  • SECTOR_CONCENTRATION_CAP:sector=Industrials:2/10:self_excluded
Failed (0)

none

Warning (1)
  • 8K_FLAG:3.01
Reward-to-Risk
3.45
Upside
+51.8%
Downside
15.0%
Sizing output
STARTER

SetupBreakout — Golden cross, above all MAs, RSI 53, MACD bullish

EdgeInst Constrain — Small cap ($0.6B) below institutional reach

SuitabilityAggressive — MCap $0.6B<$5B

Investment implication

The STRONG_BUY_WAIT verdict reflects clean gate clearance against Quality at 9.2 and asymmetric R:R of 3.45.

The strongest dimensions are Quality at 9.2, Growth at 8.2, and Value at 7.7; the weakest are Risk (lower is worse) at 4.9, Technical at 5.7, and Momentum at 5.7. The V9 engine cleared all gates with 1 warning, producing an asymmetric reward-to-risk of 3.45 and an engine sizing output of STARTER.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Elite Quality Cash Conversion

    Trip ifFree cash flow to net income falls below 100% from the current 193%.

  • P2Strong Revenue Growth

    Trip ifRevenue growth falls below 15% YoY from the current 35%.

  • P3Thin Upside Near High

    Trip ifPrice falls more than 15% below the current $7.35.

  • P4Overbought Volatility Risk

    Trip ifImplied volatility stays above 150% for 2 consecutive quarters while the price drops below $6.49.

  • P5Earnings Beat Consistency

    Trip ifQuarterly EPS falls below 0.10 from the latest 0.15.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home › Stocks › SBC › Why this verdict